Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Company Update

9 Jul 2013 14:00

RNS Number : 9025I
Ark Therapeutics Group PLC
09 July 2013
 



Ark Therapeutics Group plc

 

Company Update

 

London, UK, 9 July 2013 - Ark Therapeutics Group plc (LSE: AKT) ("Ark") confirms that the contract with Crawford Healthcare relating to the sale of the Woundcare Business sold to Crawford Healthcare in 2011 has been terminated and in return for an immediate payment of £300,000 Ark has agreed to release Crawford Healthcare from any future obligations under the contract.

 

David Venables, Non-Executive Director commented: "We have reached an amicable agreement which benefits both parties."

 

 

For further information please contact:

 

Ark Therapeutics Group plc

Tel: +44 (0)207 002 1005 

 

Iain G Ross, Non-Executive Chairman

 

David Venables, Non-Executive Director

 

 

 

This announcement includes "forward-looking statements" which include all statements other than statements of historical facts, including, without limitation, those regarding Ark's financial position, business strategy, plans and objectives of management for future operations, and any statements preceded by, followed by or that include forward-looking terminology such as the words "targets", "believes", "estimates", "expects", "aims", "intends", "will", "can", "may", "anticipates", "would", "should", "could" or similar expressions or the negative thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond Ark's control that could cause the actual results, performance or achievements of Ark to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding Ark's present and future business strategies and the environment in which Ark will operate in the future. These forward-looking statements speak only as at the date of this announcement. Ark expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this announcement to reflect any change in Ark's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. As a result of these factors, readers are cautioned not to rely on any forward-looking statement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFVADVIAIIV
Date   Source Headline
13th Jul 200610:26 amRNSHolding(s) in Company
27th Jun 20063:34 pmRNSHolding(s) in Company
21st Jun 20067:01 amRNSRe Agreement
9th Jun 20061:58 pmRNSHolding(s) in Company
5th Jun 20063:44 pmRNSBlocklisting Interim Review
22nd May 20063:52 pmRNSDirectors' Shareholdings
19th May 20063:13 pmRNSRe Placing and Open Offer
27th Apr 20063:29 pmRNSResult of AGM
27th Apr 20067:03 amRNSPlacing and Open Offer
30th Mar 20067:01 amRNSRe Agreement
28th Mar 20063:22 pmRNSAnnual Information Update
9th Mar 20067:02 amRNSFinal Results
24th Feb 20064:44 pmRNSOption Awards
15th Feb 20067:01 amRNSRe Agreement
9th Feb 200611:18 amRNSDirector Share Dealing
19th Jan 200611:12 amRNSNotice of Results
16th Jan 20067:01 amRNSResearch Update
12th Jan 20067:00 amRNSUS Patent for Kerraboot
3rd Nov 20057:01 amRNSGrant for New Facility
28th Oct 20057:01 amRNSResearch Update
28th Oct 20057:01 amRNSRegulatory Application
28th Oct 20057:01 amRNSResearch Update
20th Oct 20057:00 amRNSArk Granted Licence
18th Oct 20057:00 amRNSResearch Update
5th Oct 20057:00 amRNSoxLDL approval
13th Sep 20054:37 pmRNSHolding(s) in Company
9th Sep 20055:00 pmRNSHolding(s) in Company
9th Sep 20053:46 pmRNSHolding(s) in Company
31st Aug 20057:01 amRNSInterim Results
24th Aug 20055:56 pmRNSHolding(s) in Company
5th Aug 20057:00 amRNSResearch Update
29th Jul 20056:00 pmRNSHolding(s) in Company
28th Jul 20053:48 pmRNSNotice of Results
25th Jul 20055:28 pmRNSInterest in Shares
21st Jul 20057:01 amRNSResearch Update
7th Jul 20057:00 amRNSBoard Appointment
23rd Jun 20058:41 amRNSDirector Shareholding
21st Jun 20057:00 amRNSResearch Update
14th Jun 20057:00 amRNSSigns Marketing Deal
8th Jun 20054:41 pmRNSListing Applications
7th Jun 20053:40 pmRNSHolding(s) in Company
19th May 20057:00 amRNSKerraboot Marketing Deal
4th May 20057:00 amRNSStrengthened Patent Position
3rd May 20056:11 pmRNSHolding(s) in Company
28th Apr 20054:25 pmRNSDoc re. Result of AGM
14th Apr 20057:00 amRNSResearch Update
7th Apr 20057:00 amRNSAppointment
1st Apr 20052:43 pmRNSNotice of AGM
1st Apr 20057:00 amRNSRe Agreement
23rd Mar 20057:00 amRNSResearch Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.